Solid tumor needle biopsies are essential to confirm malignancy and assess for actionable characteristics or genetic alterations to guide treatment selection. Ensuring that sufficient and suitable material is acquired for tumor profiling, while minimizing patient risk, remains a critical unmet need. Here, we evaluated the performance characteristics of transmission optical spectroscopy for rapid identification of malignant tissue in core needle biopsies (CNB). Human kidney biopsy specimens (545 CNB from 102 patients, 5583 spectra for analysis) were analyzed directly on core biopsy needles with a custom-built optical spectroscopy instrument. Machine learning classifiers were trained to differentiate malignant from normal tissue spectra. Classifiers were compared using receiver operating characteristics analysis and sensitivity and specificity were calculated relative to a histopathologic gold standard. The best performing algorithm was the random forest (sensitivity 96% and 93%, specificity 90% and 93% at the level of individual spectra and full CNB, respectively). Ex-vivo spectroscopy paired with machine learning paves the way towards rapid and accurate characterization of CNB at the time of tissue acquisition and improving tumor biopsy quality.
Introduction
The rate of molecular diagnostic discoveries has not only increased the number of solid tumor biopsies performed but also magnified the importance of these specimens for classifying cancer and guiding treatment selection to optimize patient outcomes. 1, 2 Unfortunately, image-guided needle biopsies often fail to provide adequate material for complete characterization by cell morphology, staining properties, immunohistochemistry, or genetic signatures. 3 Rapid evaluation of specimen quality and tumor yield at the time of a biopsy could provide critical feedback to the operator, leading to more accurate and efficient tumor assessment.
Immediate biopsy specimen evaluation using cytologic imprints (touch preparations) under light microscopy can improve sampling accuracy. 4, 5 However, the resources and expertise necessary to provide rapid on-site sample assessment are far from ubiquitous. [6] [7] [8] Glass slide touch-preparation techniques can also be deleterious to downstream processing by substantially depleting the CNB of neoplastic cells or disrupting tissue architecture. 9 In pursuing cancer biopsy quality improvement, a variety of technologies and techniques have been considered for point-of-care in vivo or ex vivo tissue characterization. 10 These include optical spectroscopy, 11 x-ray imaging, 12 confocal microscopy, [13] [14] [15] structured illumination microscopy, 16 Fourier transform infrared imaging, 17 fluorescence microscopy, [18] [19] [20] [21] contrast-enhanced micrography, 22 as well as diffuse reflectance, electrical impedance, and Raman spectroscopy. [23] [24] [25] [26] Use of these technologies in a clinical setting has been hampered by factors such as lengthy analytic times, tissue degradation, expense, on-site tissue staining, requirement for interpretive expertise, and challenges to workflow integration. Additionally, many of these technologies analyze tissues in vivo, which may be helpful for determining intraoperative surgical margins but is less informative for ex vivo tissue acquired from a needle biopsy.
To facilitate ex vivo CNB quality assessment, we developed a transmission optical spectroscopy instrument that leverages machine learning methods to rapidly characterize CNB samples. Designed for bedside or procedure room clinical workflow integration, this hardware and software platform can acquire spectra from CNBs that remain intact on the biopsy needle sampling trough in less than one minute. In this study, we trained machine learning algorithms to determine whether individual transmission spectra obtained at regular intervals along a biopsy sample belong to either tumor or benign tissue classes. The robustness of classification to confounding sample types including fat, blood, and necrotic tissue was analyzed using multi-class classifiers. Additionally, a full CNB classifier, developed from the individual spectral classifier, was used to differentiate tumor-containing from benign tissue biopsies.
Histopathologic diagnoses provided by our institutional clinical pathology laboratory formed the ground truth for training all algorithms.
Using the above approach, relevant direct-to-operator feedback included analyzable specimen length, a magnified image of the tissue core, geometric proportion of the sample that contained malignant cells, and classification of the CNB sample as malignant or benign. Based on this feedback, an operator may choose to either make additional needle passes or conclude the biopsy procedure. After spectroscopic analysis, full CNB samples can then undergo standard of care diagnostic and molecular analysis, thus minimizing sources of pre-analytical variation such as percentage of samples containing low volume or no tumor.
Material and Methods

Biopsy protocol
This study was approved by the institutional review board and human biospecimen utilization committee. Surgically excised human kidney specimens from April 2013 through October 2014 were biopsied ex vivo in a tissue procurement facility immediately after partial or complete nephrectomy for renal cell carcinoma. The distinction between normal and tumor regions was made by gross examination of pathology specimens. Biopsies were obtained using 18-gauge side-notch, spring-loaded core needle devices with 20 mm-long sampling troughs exposed (Temno Evolution or Adjustable Coaxial Temno, CareFusion Corporation, San Diego, CA). Kidney tumor and normal renal parenchymal were sampled in addition to renal sinus fat, visibly necrotic tissues, and blood. The histopathologic diagnosis of each tumor was recorded for association with spectroscopy data.
Optical spectroscopy
Biopsy samples were analyzed using a custom-built automated transmission optical spectrometer ( Figure 1A Imaging was performed directly across the CNB sampling trough ( Figure 1B) . A custom snap-in acrylonitrile butadiene styrene 3D-printed needle holder was used to align the tip of the needle with the illumination beam prior to scanning ( Figure 1C ). Light transmitted through the tissue sample was collected by fused silica lens (74-UV) and fiber-optically guided to a spectrometer coupled with a multi-channel array detector (Horiba, VS70, spectral window: 190-1000 nm, Kyoto, Japan). 
Spectrum pre-processing
The acquired transmittance spectra were normalized to values between 0 and 1 by subtracting the dark spectrum and dividing by the reference spectrum. Low signal spectra due to obstruction of the light path by the needle, or saturated spectra due to 100% transmittance in unfilled sampling trough regions, as well as spectra outside the region of biopsy trough did not contain any tissue, resulting in outlier spectra (black) that were not classified.
Automatic tissue classification using machine learning
All machine learning classifiers were trained on 80% of the data and tested on the remaining 20%. The training-test set split was randomized and stratified, and classifier hyperparameters were tuned using 10-fold stratified cross validation on the training set. All programming was carried out using MATLAB software. 28 Machine learning classifiers were trained on the extracted principal spectral components to differentiate tumor spectra from normal tissue spectra. The ground truth labels for spectra were obtained from the histopathologic findings. The classification algorithms included LR, SVM, and RF. 25, 29 The probability of a given spectrum belonging to tumor tissue was obtained as output from each classifier. The spectra were designated as either tumor or normal based on an optimal decision threshold on the probability of tumor ( > ℎ ). To test the robustness of classification to confounders, the analysis was repeated with three additional types of tissue spectra commonly obtained during clinical kidney mass CNBs: renal sinus fat, blood, and necrotic tumors.
New multi-class classification models were trained to obtain probabilities of each spectrum belonging to one of the 5 classes. The multi-class output was further collapsed to a binary classification output, where a spectrum was designated as positive if classified as either viable or necrotic renal cell carcinoma and was designated as negative if classified as any of normal renal parenchyma, blood, or renal sinus fat.
Tissue classification was performed both at the individual spectrum and the full CNB sample levels. The probability of a full CNB sample representing predominantly tumor or normal tissue was computed by combining the likelihood of each of its constituent spectrum via a signal fusion approach and using naive Bayes assumption (Appendix A). The full CNB sample was designated as either tumor or normal based on an optimal decision threshold on the probability of tumor ( > ℎ )
Performance evaluation
Individual spectral and whole biopsy classifiers were quantitatively evaluated using ROC analysis and scalar performance metrics at their respective optimal decision thresholds. The optimal decision thresholds, ℎ and ℎ , for the spectral and full CNB sample classifiers were computed using the Zweig and Campbell method 30 
Results
Patients and Samples
Five hundred and forty-five CNBs were obtained from surgically resected kidneys from 102 patients undergoing partial or complete nephrectomy for renal cell carcinoma, resulting in 5583 spectra after pre-processing. Coring needles were advanced into selected regions based on direct tissue visualization and correlation with prior radiographic imaging studies. Sampled tissues included renal cell carcinoma, normal renal parenchyma, renal sinus fat, blood, and necrotic tumor (see Table 1 for the distribution of sampled tissues). Large tumor regions and normal (or non-tumor) tissue regions were sampled under the guidance of pathologists to ensure that samples contained either entirely tumor or entirely non-tumor tissues. The maximum scan duration was up to 60 sec for a full-trough biopsy sample. 
Classifier Performance
Robustness of Classification Analyzed using Multi-class Classifiers
Multi-class classification results were collapsed to a binary classification output, with tumor/necrotic tissues considered positive and normal tissues. Meanwhile, blood and fat considered negative. Here again, the RF achieved the best performance here as well with an AUC of 0.96. Table 2 shows the scalar performance metrics (at optimal receiver operating curve (ROC) thresholds) for both the binary classification (top half) and the multi -class 14 classification collapsed to a binary output (bottom half). RF achieved the best performance in both cases. At optimal ROC thresholds ( ℎ of 0.59 and 0.57), the sensitivities were 96% and 92% and specificities were 90% and 89% for the binary and multi-class analyses, respectively. Full CNB Classifier Figure 5 shows the results of classifying the full CNB specimen, rather than single location individual spectra, as tumor or normal tissue. The best performing 16 spectral classifier, RF, was used to build the full CNB classifier. At the optimal ROC threshold of ℎ = 0.02, the sensitivity and specificity were 93% and 91% respectively.
Relative Performance of Classification Algorithms
These results show that full CNBs can be classified with high fidelity. 
Heat Maps as Visualization Tools
Discussion
Automated biological sample analyses that pair imaging with machine learning have shown to be both promising and challenging. 29 Our study suggests that optical spectroscopy combined with machine learning can quickly and accurately characterize kidney CNB samples obtained for cancer diagnostics. The combination of an imaging modality, a reference library of tissue characteristics, a computational platform, and data networking may effectively close the physical and temporal gap between operating rooms or biopsy suites (tissue acquisition) and pathology departments (tissue analysis).
A variety of optical technologies for rapid high-resolution tissue imaging have been proposed and evaluated in the past, each with potential advantages and disadvantages in terms of portability, infrastructure requirements, ease of use, and cost. 10, 31, 32 Relative to alternative systems that permit in vivo tissue characterization prior to biopsy using optical coherence tomography or elastography needle probes, 11 the instrument studied here was designed to assess the ex vivo material obtained from the targeted lesion. This offers the advantage of providing feedback to the operator regarding the actual sample destined for downstream processing rather than a potential Lastly, a common criticism of machine learning classification algorithms to automate diagnoses is that there may be limited insight into the specific determinants used for classification. In this study, the underlying biological basis for critical spectral features is not known. Further efforts to improve classifier accountability may benefit from advances in the field of machine learning as a whole.
Point-of-acquisition tissue assessment using instruments such as the optical spectroscopy and machine learning platform described in this study could help to establish a new performance standard for rapid cancer biopsy assessment and automated needle biopsy quality control. The transformative potential of this technology is increasingly evident in the era of molecular oncology, where personalized cancer treatments require accurate and often repeated profiling of continually mutating cancer cell populations. 29 Table 2 . Statistical performance metrics comparing the spectral classifiers including logistic regression (LR), support vector machine (SVM), and random forest (RF). The top half of the table reflects binary tumor vs normal tissue spectral classification; the bottom half shows multiclass classification with confounders collapsed to a binary output (positive class: tumor, necrotic tissue spectra; negative class: fat, blood and normal tissue spectra). All the metrics were computed at their respective optimal ROC thresholds.
Tables
Algorithm Sensitivity (%) Specificity (%) Accuracy (%) PPV (%) NPV (%)
Tumor vs normal tissue spectrum classifier
